Loading...
Loading...
Of the 13 tracked institutions holding GSK, 8 have a 3-year clone track record — 5 of them beat the S&P. Average holder's clone alpha: +2.5pt. It's a gauge of who owns the name, not just how many.
Among the 13 tracked institutional investors we monitor, GSK (GSK PLC) is held with a combined value of $7.54B across 136,581,044 shares. The largest holder is FMR LLC with a position worth $3.73B (0.20% of their portfolio). 5 funds increased their holdings. 8 funds reduced their position.
Total Institutional Value
$7.54B
Total Shares Held
136,581,044
Institutional Holders
13
% of Shares Outstanding
3.2%
of 4.32B shares · SEC 2025-12-31
Days to Cover
4.5+7.9%
13.76M shares short · FINRA 2026-07-15
Tracked 13F institutions hold 3.2% of GSK's shares outstanding. This is a floor: 13F filings arrive on a ~45-day lag and we track only a subset of institutional filers, so true institutional ownership is higher. Shares-outstanding is the latest SEC cover-page figure (as of 2025-12-31), not a live float.
Ranked by estimated dollars moved (share change × implied price). 13F data lags up to 45 days.
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | FMR LLC | $3.73B | 0.20% | +0.3% |
| 2 | Fisher Asset Management, LLC | $1.91B | 0.65% | +4.0% |
| 3 | WELLINGTON MANAGEMENT GROUP LLP | $646.70M | 0.12% | -6.7% |
| 4 | PRICE T ROWE ASSOCIATES INC /MD/ | $404.15M | 0.05% | -7.2% |
| 5 | STATE STREET CORP | $334.02M | 0.01% | -4.1% |
| 6 | BlackRock, Inc. | $195.97M | 0.00% | +95.7% |
| 7 | Grantham, Mayo, Van Otterloo & Co. LLC | $194.41M | 0.50% | +1.0% |
| 8 | Bridgewater Associates, LP | $38.56M | 0.17% | -50.7% |
| 9 | MILLENNIUM MANAGEMENT LLC | $37.19M | 0.02% | -2.8% |
| 10 | RENAISSANCE TECHNOLOGIES LLC | $17.18M | 0.03% | -69.9% |
| Member | Type | Date |
|---|---|---|
| Lisa McClain | Sell | Oct 31, 2025 |
| Lisa McClain | Buy | Oct 30, 2025 |
| Lisa McClain | Sell | Oct 30, 2025 |
| Valerie Hoyle | Sell |
As of the latest SEC 13F filings, FMR LLC is the largest institutional holder of GSK with a position worth $3.73B, representing 0.20% of their portfolio. In total, 13 institutional investors hold GSK with a combined value of $7.54B.
Institutional investors hold $7.54B worth of GSK stock across 13 positions. The largest institutional holder is FMR LLC with $3.73B in holdings.
A 13F filing is a quarterly report required by the SEC from institutional investment managers with over $100 million in assets. It discloses their holdings in U.S. equities. For GSK, these filings reveal which major funds are accumulating or reducing positions, providing insights into institutional sentiment.
Get notified when hedge funds change their GSK positions.
Alpha = the manager's 3-year clone return minus the S&P 500. A skilled roster is a stronger tell than a crowded one — though even skilled managers' edge doesn't reliably survive the 13F disclosure lag. Why →
| Sep 23, 2025 |
| Lisa McClain | Buy | Aug 4, 2025 |
| Robert B. Aderholt | Sell | Jul 28, 2025 |
| Lisa McClain | Sell | Jun 24, 2025 |
| Lisa McClain | Buy | Jun 17, 2025 |
Showing 8 of 14. STOCK Act disclosures lag up to 45 days.
Last Close
$51.35
2026-07-24
YTD
+3.5%
61% of 52-week range